DEL FABRO, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 654
AS - Asia 541
EU - Europa 247
SA - Sud America 133
Continente sconosciuto - Info sul continente non disponibili 44
AF - Africa 13
Totale 1.632
Nazione #
US - Stati Uniti d'America 621
SG - Singapore 184
IT - Italia 112
BR - Brasile 110
HK - Hong Kong 98
BD - Bangladesh 91
CN - Cina 62
VN - Vietnam 46
FR - Francia 34
DE - Germania 25
CA - Canada 20
IE - Irlanda 17
GB - Regno Unito 16
IN - India 13
AR - Argentina 9
NL - Olanda 8
PL - Polonia 8
TR - Turchia 8
AT - Austria 7
MX - Messico 7
CO - Colombia 5
IQ - Iraq 5
CL - Cile 4
IL - Israele 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
EG - Egitto 3
ES - Italia 3
FI - Finlandia 3
ID - Indonesia 3
PK - Pakistan 3
RU - Federazione Russa 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
JP - Giappone 2
LT - Lituania 2
NP - Nepal 2
SE - Svezia 2
UZ - Uzbekistan 2
AL - Albania 1
EC - Ecuador 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
MY - Malesia 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
RW - Ruanda 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
Totale 1.588
Città #
Dallas 227
Hong Kong 98
Singapore 86
San Jose 68
Ashburn 60
The Dalles 35
Chicago 32
Beijing 26
Ho Chi Minh City 22
Florence 21
New York 18
Dublin 17
Santa Clara 17
Rome 14
Buffalo 12
Milan 9
São Paulo 9
Assago 8
Frankfurt am Main 8
Los Angeles 8
Düsseldorf 6
Hanoi 6
Naples 6
San Francisco 6
Charlotte 5
Istanbul 5
Baghdad 4
Bexley 4
Brooklyn 4
Hillsboro 4
Manchester 4
Mexico City 4
Orem 4
Toronto 4
Warsaw 4
Bogotá 3
Bologna 3
Brasília 3
Catania 3
Da Nang 3
Jeddah 3
London 3
Mumbai 3
Reston 3
Turin 3
Abbotsford 2
Addis Ababa 2
Atlanta 2
Baku 2
Bari 2
Belo Horizonte 2
Boston 2
Campinas 2
Cape Town 2
Changsha 2
Diadema 2
Fortaleza 2
Haiphong 2
Helsinki 2
Independencia 2
Juneau 2
Lauterbourg 2
Lençóis Paulista 2
Montreal 2
Newark 2
Nuremberg 2
Phoenix 2
Pune 2
Rio de Janeiro 2
São Bernardo do Campo 2
Tashkent 2
Tel Aviv 2
Vancouver 2
Wroclaw 2
Abu Dhabi 1
Adana 1
Agudos 1
Ahmedabad 1
Albox 1
Alegre 1
Alexandria 1
Allentown 1
Almere Stad 1
Alto Araguaia 1
Amsterdam 1
Ananindeua 1
Ancona 1
Ankara 1
Anápolis 1
Aquiraz 1
Aracaju 1
Araçatuba 1
As Sālimīyah 1
Bacabal 1
Barcelona 1
Barra Mansa 1
Beirut 1
Belém 1
Bengaluru 1
Berazategui 1
Totale 979
Nome #
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 87
Serum free light chains and multiple myeloma: Is it time to extend their application? 71
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey 69
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over 69
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape 65
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia 64
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies 63
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions 62
Feasibility, tolerability and efficacy of carfilzomib in combination with lenalidomide and dexamethasone in relapsed refractory myeloma patients: A retrospective real-life survey of the sicilian myeloma network 62
Long-Term Survival with Daratumumab, Lenalidomide and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients—A Survey from Two Italian Centers 61
IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical Aspects 60
Multiple Myeloma in 2023 Ways: From Trials to Real Life 57
Emergencies in Hematology: Why, When and How I Treat? 56
Chemotherapy extravasation: diagnosis, prevention and management 55
IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia 53
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study 53
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 50
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones? 48
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 48
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 47
Clinical benefit of long-term disease control with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients 47
Lenalidomide and pomalidomide improve function and induce fcγri/cd64 in multiple myeloma neutrophils 44
Role of serum free light chain assay in relapsed/refractory multiple myeloma. A real‐life unicentric retrospective study 43
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection 42
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 42
Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review 38
Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network 32
Pericytes and mesenchymal stromal cells converge toward pro-tumor phenotypes in the tumor microenvironment 29
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 27
Hodgkin-Inflammatory-Based Model ME-IPS Is a New Inflammatory-Based Prognostic Model Calculated at Diagnosis: Results From a Real-Life Study 23
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 22
Diffuse large B-cell lymphoma in the new era: prognostic tools for mapping risk 19
Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti-CD38 monoclonal antibodies: outcomes from a real-world experience 14
Glutamate accumulation in myelofibrosis microenvironment rewires mesenchymal stromal cells metabolic and epigenetic profiles 5
Heme oxygenase-1/CO signaling suppresses NLRP3 inflammasome-mediated stromal fibrosis in primary myelofibrosis 5
Totale 1.632
Categoria #
all - tutte 7.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025445 0 0 0 7 10 95 31 80 41 79 66 36
2025/20261.142 71 167 161 105 54 61 84 92 87 62 131 67
2026/202745 18 27 0 0 0 0 0 0 0 0 0 0
Totale 1.632